CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- 4 Grant or award President and CEO acquired 167,005 shares (grant or award)
- 4 Grant or award COO & CBO acquired 95,889 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 95,889 shares (grant or award)
- 4 Gift President and CEO gave 100,000 shares (gift)
- 4 Option exercise COO & CBO acquired 19,000 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 19,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 19,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 109,000 shares (option exercise)
- 4 Gift Chief Scientific Officer gave 86,166 shares (gift)
- 4 Grant or award Director acquired 36,250 shares (grant or award)
- 4 Grant or award President and CEO acquired 559,640 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 236,331 shares (grant or award)
- 4 Grant or award COO & CBO acquired 212,328 shares (grant or award)
- 4 Grant or award Director acquired 33,500 shares (grant or award)
- 4 Grant or award Director acquired 34,900 shares (grant or award)
- 4 Grant or award Director acquired 36,250 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 196,216 shares (grant or award)
- 4 Grant or award Director acquired 36,975 shares (grant or award)
- 4 Grant or award Director acquired 38,371 shares (grant or award)
- 4 Grant or award Director acquired 38,370 shares (grant or award)
Page 2 of 16 · 306 filings